0001493152-24-023767.txt : 20240613 0001493152-24-023767.hdr.sgml : 20240613 20240613195940 ACCESSION NUMBER: 0001493152-24-023767 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240611 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lawrence Bryan Jay CENTRAL INDEX KEY: 0002011767 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40874 FILM NUMBER: 241042710 MAIL ADDRESS: STREET 1: C/O CINGULATE INC. STREET 2: 1901 W. 47TH PLACE CITY: KANSAS CITY STATE: KS ZIP: 66205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cingulate Inc. CENTRAL INDEX KEY: 0001862150 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863825535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1901 W. 47TH PLACE CITY: KANSAS CITY STATE: KS ZIP: 66205 BUSINESS PHONE: (913) 942-2300 MAIL ADDRESS: STREET 1: 1901 W. 47TH PLACE CITY: KANSAS CITY STATE: KS ZIP: 66205 4 1 ownership.xml X0508 4 2024-06-11 0 0001862150 Cingulate Inc. CING 0002011767 Lawrence Bryan Jay 1901 W. 47TH PLACE KANSAS CITY KS 66205 1 0 0 0 0 Stock Option (right to Buy) 1.18 2024-06-11 4 A 0 5000 0 A 2034-03-04 Common Stock 5000 5000 D Stock Option (right to Buy) 1.18 2024-06-11 4 A 0 14125 A 2034-03-04 Common Stock 14125 14125 D Stock Option (right to Buy) 0.70 2024-06-12 4 A 0 10000 0 A 2034-06-12 Common Stock 10000 10000 D The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the "Amendment"). Cingulate's stockholders approved the Amendment on June 11, 2024. The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares on the twelve-month anniversary of the date of grant. The option vests on the one-year anniversary of the date of grant. The option was issued to the reporting person in lieu of cash retainer fees of $28,250. /s/ Shane J. Schaffer, Attorney-in-Fact 2024-06-13